Shanghai Henlius Biotech Statistics

Total Valuation

HKG:2696 has a market cap or net worth of HKD 20.49 billion. The enterprise value is 23.51 billion.

Market Cap	20.49B
Enterprise Value	23.51B

Important Dates

The next estimated earnings date is Tuesday, May 27, 2025.

Earnings Date	May 27, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:2696 has 543.49 million shares outstanding. The number of shares has increased by 0.02% in one year.

Current Share Class	n/a
Shares Outstanding	543.49M
Shares Change (YoY)	+0.02%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.59%
Owned by Institutions (%)	6.13%
Float	68.28M

Valuation Ratios

The trailing PE ratio is 23.47.

PE Ratio	23.47
Forward PE	n/a
PS Ratio	3.36
PB Ratio	6.39
P/TBV Ratio	n/a
P/FCF Ratio	17.86
P/OCF Ratio	15.50
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.90, with an EV/FCF ratio of 20.49.

EV / Earnings	26.92
EV / Sales	3.86
EV / EBITDA	17.90
EV / EBIT	25.49
EV / FCF	20.49

Financial Position

The company has a current ratio of 0.50, with a Debt / Equity ratio of 1.21.

Current Ratio	0.50
Quick Ratio	0.34
Debt / Equity	1.21
Debt / EBITDA	2.96
Debt / FCF	3.38
Interest Coverage	7.05

Financial Efficiency

Return on equity (ROE) is 31.52% and return on invested capital (ROIC) is 8.37%.

Return on Equity (ROE)	31.52%
Return on Assets (ROA)	5.28%
Return on Invested Capital (ROIC)	8.37%
Return on Capital Employed (ROCE)	15.57%
Revenue Per Employee	1.73M
Profits Per Employee	248,399
Employee Count	3,515
Asset Turnover	0.56
Inventory Turnover	2.07

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +155.24% in the last 52 weeks. The beta is 0.83, so HKG:2696's price volatility has been lower than the market average.

Beta (5Y)	0.83
52-Week Price Change	+155.24%
50-Day Moving Average	29.08
200-Day Moving Average	23.77
Relative Strength Index (RSI)	68.68
Average Volume (20 Days)	1,931,506

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:2696 had revenue of HKD 6.09 billion and earned 873.12 million in profits. Earnings per share was 1.61.

Revenue	6.09B
Gross Profit	4.45B
Operating Income	922.11M
Pretax Income	900.16M
Net Income	873.12M
EBITDA	1.24B
EBIT	922.11M
Earnings Per Share (EPS)	1.61

Full Income Statement

Balance Sheet

The company has 865.95 million in cash and 3.88 billion in debt, giving a net cash position of -3.02 billion or -5.55 per share.

Cash & Cash Equivalents	865.95M
Total Debt	3.88B
Net Cash	-3.02B
Net Cash Per Share	-5.55
Equity (Book Value)	3.21B
Book Value Per Share	5.90
Working Capital	-2.68B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.32 billion and capital expenditures -174.53 million, giving a free cash flow of 1.15 billion.

Operating Cash Flow	1.32B
Capital Expenditures	-174.53M
Free Cash Flow	1.15B
FCF Per Share	2.11

Full Cash Flow Statement

Margins

Gross margin is 73.10%, with operating and profit margins of 15.14% and 14.33%.

Gross Margin	73.10%
Operating Margin	15.14%
Pretax Margin	14.78%
Profit Margin	14.33%
EBITDA Margin	20.30%
EBIT Margin	15.14%
FCF Margin	18.83%

Dividends & Yields

HKG:2696 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.02%
Shareholder Yield	-0.02%
Earnings Yield	4.26%
FCF Yield	5.60%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:2696 has an Altman Z-Score of 0.87. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.87
Piotroski F-Score	n/a